Cargando…
Thymosin α1 represents a potential potent single molecule-based therapy for cystic fibrosis
Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) that compromise its chloride-channel activity. The most common mutation, p.Phe508del, results in the production of a misfolded CFTR protein, which has residual channel acti...
Autores principales: | Romani, Luigina, Oikonomou, Vasilis, Moretti, Silvia, Iannitti, Rossana G., D’Adamo, Maria Cristina, Villella, Valeria R., Pariano, Marilena, Sforna, Luigi, Borghi, Monica, Bellet, Marina M., Fallarino, Francesca, Pallotta, Maria Teresa, Servillo, Giuseppe, Ferrari, Eleonora, Puccetti, Paolo, Kroemer, Guido, Pessia, Mauro, Maiuri, Luigi, Goldstein, Allan L., Garaci, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420451/ https://www.ncbi.nlm.nih.gov/pubmed/28394330 http://dx.doi.org/10.1038/nm.4305 |
Ejemplares similares
-
A Reappraisal of Thymosin Alpha1 in Cancer Therapy
por: Costantini, Claudio, et al.
Publicado: (2019) -
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease
por: Renga, Giorgia, et al.
Publicado: (2019) -
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections
por: Bellet, Marina M., et al.
Publicado: (2023) -
Thymosin α1 protects from CTLA-4 intestinal immunopathology
por: Renga, Giorgia, et al.
Publicado: (2020) -
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy
por: van de Veerdonk, Frank L., et al.
Publicado: (2022)